These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 1825244
1. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Cheigh JS, Suthanthiran M, Fotino M, Riggio RR, Schechter N, Stubenbord WT, Stenzel KH, Rubin AL. Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244 [Abstract] [Full Text] [Related]
2. Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion. Cheigh JS, Suthanthiran M, Fotino M, Kaplan M, Evelyn M, Schechter N, Wolf CF, Riggio RR, Riehle R, Stubenbord WT. Uremia Invest; 1991 Feb; 9(1):11-7. PubMed ID: 2940741 [Abstract] [Full Text] [Related]
3. Optimization of donor specific blood transfusion in kidney transplantation. Cheigh JS, Suthanthiran M, Stubenbord WT, Fotino M, Riggio RR, Schechter N, Stenzel KH, Rubin AL. Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891 [Abstract] [Full Text] [Related]
4. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients. Sharma RK, Rai PK, Kumar A, Kumar P, Gupta A, Kher V, Agrawal S, Bhandari M. Nephron; 1997 Feb; 75(1):20-4. PubMed ID: 9031265 [Abstract] [Full Text] [Related]
5. [The effect of donor specific blood transfusion (DST) on graft survival--intermittent coverage of cyclophosphamide]. Kasai I, Kumano K, Iwamura M, Yoshida K, Mashimo S, Endo T, Saaki T, Koshiba K, Kikuo I, Uchida H. Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):367-71. PubMed ID: 2359213 [Abstract] [Full Text] [Related]
6. [Effect of donor-specific blood transfusion on the outcome of kidney transplantation]. Jovicić-Pavlović S, Lezaić V, Simić S, Blagojević-Lazić R, Stolić I, Simonović R, Radivojević-Djokić D, Djukanović L. Srp Arh Celok Lek; 2003 Mar; 131(11-12):449-53. PubMed ID: 15114786 [Abstract] [Full Text] [Related]
7. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience. Satoh S, Sugimura J, Omori S, Seino K, Fujizuka I. Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995 [Abstract] [Full Text] [Related]
8. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Salvatierra O, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ. Transplantation; 1985 Dec; 40(6):654-9. PubMed ID: 3907038 [Abstract] [Full Text] [Related]
10. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Sonoda T, Ishibashi M. Clin Transpl; 1987 Dec; ():257-60. PubMed ID: 2978999 [Abstract] [Full Text] [Related]
11. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival. Oluwole SF, Lau HT, Reemtsma K, Hardy MA. Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417 [Abstract] [Full Text] [Related]
12. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Lazda VA, Pollak R, Mozes MF, Barber PL, Jonasson O. Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251 [Abstract] [Full Text] [Related]
13. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB. Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863 [Abstract] [Full Text] [Related]
14. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization. Martinelli GP, Horowitz C, Chiang K, Racelis D, Schanzer H. Transplantation; 1987 Jan 27; 43(1):140-5. PubMed ID: 3541314 [Abstract] [Full Text] [Related]
15. Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions, and cyclosporine on outcome. Sanfilippo F, Thacker L, Vaughn WK. Transplantation; 1990 Jan 27; 49(1):25-9. PubMed ID: 2301022 [Abstract] [Full Text] [Related]
16. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes. Burlingham WJ, Grailer A, Sparks-Mackety EM, Sondel PM, Sollinger HW. Transplantation; 1987 Jan 27; 43(1):41-6. PubMed ID: 2948309 [Abstract] [Full Text] [Related]
17. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine. Brunson ME, Tchervenkov JI, Alexander JW. Transplantation; 1991 Sep 27; 52(3):545-9. PubMed ID: 1716800 [Abstract] [Full Text] [Related]
18. Donor specific transfusions or cyclosporine for related-donor kidney transplantation? Jayes RL, Levey AS. Kidney Int; 1989 Sep 27; 36(3):485-96. PubMed ID: 2593493 [Abstract] [Full Text] [Related]
19. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Alexander JW, Light JA, Donaldson LA, Delmonico FL, Diethelm AG, Wilkinson A, Rosenthal JT, Thistlethwaite JR, Hunsicker LG, Matas AJ, First MR, Reinsmoen NL, Rose SM. Transplantation; 1999 Oct 27; 68(8):1117-24. PubMed ID: 10551639 [Abstract] [Full Text] [Related]
20. Donor-specific blood transfusions versus cyclosporine--the DST story. Salvatierra O, Melzer J, Vincenti F, Amend WJ, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ. Transplant Proc; 1987 Feb 27; 19(1 Pt 1):160-6. PubMed ID: 3547813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]